These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8215009)

  • 21. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
    van Burik JH; Leisenring W; Myerson D; Hackman RC; Shulman HM; Sale GE; Bowden RA; McDonald GB
    Medicine (Baltimore); 1998 Jul; 77(4):246-54. PubMed ID: 9715729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
    Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G
    Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children].
    Ishikawa Y; Shimizu T; Sakiyama Y; Matsumoto S; Hatae Y; Takeda T; Ishikawa A; Takase A; Wagatsuma Y
    Jpn J Antibiot; 1994 Mar; 47(3):268-71. PubMed ID: 8182897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and prevention of neonatal candidiasis: fluconazole for all neonates?
    Kaufman DA
    Adv Exp Med Biol; 2010; 659():99-119. PubMed ID: 20204759
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of fluconazole prophylaxis on the incidence of invasive candida infections and bacteraemias in patients with acute leukaemia.
    Nihtinen A; Anttila VJ; Elonen E; Juvonen E; Volin L; Ruutu T
    Eur J Haematol; 2008 May; 80(5):391-6. PubMed ID: 18221387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.
    Cesaro S; Rossetti F; Perilongo G; Rossi L; Zanesco L
    Haematologica; 1993; 78(4):249-51. PubMed ID: 8294059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
    Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
    Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic fluconazole and Candida krusei infection.
    Schuler U; Ehninger G
    N Engl J Med; 1992 Mar; 326(13):892; author reply 892-3. PubMed ID: 1542333
    [No Abstract]   [Full Text] [Related]  

  • 29. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis.
    McIlroy MA
    J Infect Dis; 1991 Feb; 163(2):420-1. PubMed ID: 1988531
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
    Kaufman DA; Morris A; Gurka MJ; Kapik B; Hetherington S
    Early Hum Dev; 2014 Mar; 90 Suppl 1():S87-90. PubMed ID: 24709470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal prophylaxis with weekly fluconazole for patients with AIDS.
    Mylonakis E; Flanigan TP
    Clin Infect Dis; 1998 Dec; 27(6):1376-8. PubMed ID: 9868645
    [No Abstract]   [Full Text] [Related]  

  • 32. Antifungal prophylaxis: identification of preterm neonates at highest risk for invasive fungal infection.
    Vendettuoli V; Vento G; Tirone C; Posteraro B; Romagnoli C
    Pediatrics; 2009 Feb; 123(2):e368-9. PubMed ID: 19171602
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic fluconazole and Candida krusei infections.
    Tam JY; Blume KG; Prober CG
    N Engl J Med; 1992 Mar; 326(13):891; author reply 892-3. PubMed ID: 1343806
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
    Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
    J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia.
    Wingard JR
    Leuk Lymphoma; 1992 Nov; 8(4-5):353-9. PubMed ID: 1290959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time.
    Neely MN; Schreiber JR
    Pediatrics; 2001 Feb; 107(2):404-5. PubMed ID: 11158475
    [No Abstract]   [Full Text] [Related]  

  • 37. [The significance of fluconazole (diflucan) in the therapy and prevention of candidiasis and cryptococcosis].
    Müller J
    Mycoses; 1990; 33 Suppl 1():65-7. PubMed ID: 2101866
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country.
    Rueda K; Moreno MT; Espinosa M; Sáez-Llorens X
    Pediatr Infect Dis J; 2010 Nov; 29(11):1050-2. PubMed ID: 20571460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluconazole prophylaxis for high-risk liver transplant recipients.
    Kung N; Fisher N; Gunson B; Hastings M; Mutimer D
    Lancet; 1995 May; 345(8959):1234-5. PubMed ID: 7739317
    [No Abstract]   [Full Text] [Related]  

  • 40. Liposomal amphotericin B for fever and neutropenia.
    Wingard JR
    N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.